Principia Biopharma Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Principia Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Principia Biopharma Inc. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | M | 4.54 | 5,504 | 24,999 | 19,047 | |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 46.36 | 3,750 | 173,838 | 35,609 | 39.4 K to 35.6 K (-9.53 %) |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 45.72 | 1,754 | 80,192 | 39,359 | 41.1 K to 39.4 K (-4.27 %) |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Buy | M | 4.54 | 5,504 | 24,999 | 41,113 | 35.6 K to 41.1 K (+15.46 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 5,000 | 23,618 | 7,758 | |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 51.04 | 100 | 5,104 | 116,903 | 117 K to 116.9 K (-0.09 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.46 | 1,181 | 58,408 | 117,003 | 118.2 K to 117 K (-1.00 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 48.21 | 3,719 | 179,304 | 118,184 | 121.9 K to 118.2 K (-3.05 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 5,000 | 23,618 | 121,903 | 116.9 K to 121.9 K (+4.28 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | A | 67.31 | 55,000 | 3,702,050 | 55,000 | |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | A | 67.31 | 55,000 | 3,702,050 | 55,000 | |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | A | 67.31 | 55,000 | 3,702,050 | 55,000 | |
| Mar 05 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | A | 67.31 | 55,000 | 3,702,050 | 55,000 | |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | A | 67.31 | 75,000 | 5,048,250 | 75,000 | |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | A | 67.31 | 200,000 | 13,462,000 | 200,000 | |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 64.83 | 300 | 19,448 | 39,179 | 39.5 K to 39.2 K (-0.76 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 64.10 | 5,432 | 348,180 | 39,479 | 44.9 K to 39.5 K (-12.10 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 63.24 | 7,183 | 454,251 | 44,911 | 52.1 K to 44.9 K (-13.79 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 62.45 | 2,085 | 130,203 | 52,094 | 54.2 K to 52.1 K (-3.85 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Gift | G | 0.00 | 1,159 | 0 | 18,355 | 17.2 K to 18.4 K (+6.74 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Gift | G | 0.00 | 1,159 | 0 | 0 | 1.2 K to 0 (-100.00 %) |